Access to tirzepatide (Mounjaro®) in West Yorkshire

Posted by: nicolapaxman - Posted on:

a person with an insulin injection pen

Tirzepatide, commonly known as Mounjaro, is a weekly injection shown to help weight loss and improve related health conditions. From 23 June 2025 a small number of GP practices in West Yorkshire started to contact people who might be medically eligible for this treatment to invite them for a clinical assessment.

This phased rollout follows updated guidance from the National Institute for Health and Care Excellence (NICE)and is part of a national staged programme aimed at improving health outcomes for people living with obesity and related conditions such as type 2 diabetes, high blood pressure and heart disease.

  • Mounjaro is being introduced in a small number of GP practices as part of wider support for people living with obesity
  • It is only available to a limited number of patients in the first year, based on strict NHS criteria
  • Eligibility includes a BMI of 40 or more and at least four serious weight-related health conditions
  • Patients must also take part in a structured support programme (wraparound care) including healthy eating and physical activity
  • There is no need to contact your GP practice – eligible patients will be contacted directly by their practice or the NHS

We understand this can be difficult

If you’re living with obesity or weight-related health issues, we understand that the journey can be emotional, frustrating, and difficult – especially when services feel out of reach. That’s why in West Yorkshire, we are committed to taking a trauma-informed approach.

This means recognising the emotional toll that stigma, exclusion, and inconsistent access can have – and doing our best to provide compassionate support that meets people where they are.

Not everyone will be eligible for medication right now. But this is not a reflection of your effort, your worth, or your need. We are building a system that includes a wide range of support—what we call the Pillars of Support – which are available to everyone, whether or not medication is part of your journey.

5. FAQs (attached)

Please read, share, and brief your frontline GP practice and PALS staff using these FAQ responses.We have also published:

If new topics or recurring questions begin to emerge, please let your Communications Team contact know so we can keep this information updated.